awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q53817434-46B57E99-9A20-4BB4-BD19-B0EBB1E8366B
Q53817434-46B57E99-9A20-4BB4-BD19-B0EBB1E8366B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53817434-46B57E99-9A20-4BB4-BD19-B0EBB1E8366B
A phase II study of AT9283, an aurora kinase inhibitor, in patients with relapsed or refractory multiple myeloma: NCIC clinical trials group IND.191.
P2860
Q53817434-46B57E99-9A20-4BB4-BD19-B0EBB1E8366B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53817434-46B57E99-9A20-4BB4-BD19-B0EBB1E8366B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a8c0aa6388bcaefed9e5f717a069bd0cc009bc2b
P2860
Phase I study assessing the safety and tolerability of barasertib (AZD1152) with low-dose cytosine arabinoside in elderly patients with AML